We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $1.26B
1-Year Est. Return 95.39%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+95.39%
3 Year Est. Return
+360.87%
5 Year Est. Return
+519.82%
10 Year Est. Return
+3,025.56%
AUM
$892M
AUM Growth
-$93.5M
Cap. Flow
-$101M
Cap. Flow %
-11.37%
Top 10 Hldgs %
31.04%
Holding
390
New
36
Increased
60
Reduced
190
Closed
62

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$12M
2
STX icon
Seagate
STX
+$10.9M
3
UI icon
Ubiquiti
UI
+$6.46M
4
IDXX icon
Idexx Laboratories
IDXX
+$5.31M
5
NVT icon
nVent Electric
NVT
+$4.54M

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$12.7M
2
AXON
Axon Enterprise
AXON
+$10.2M
3
PGR icon
Progressive
PGR
+$9.78M
4
NTNX icon
Nutanix
NTNX
+$6.04M
5
AROC icon
Archrock
AROC
+$5.73M

Sector Composition

Rank Sector Weight
1 Technology 26.86%
2 Industrials 23.46%
3 Healthcare 10.94%
4 Materials 8.12%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APPF icon
301
AppFolio
APPF
$6.84B
$233K 0.03%
1,000
AEP icon
302
American Electric Power
AEP
$68.8B
$231K 0.03%
2,000
-2,917
-59% -$345K
XYL icon
303
Xylem
XYL
$28.5B
$229K 0.03%
1,678
+5
+0.3% +$719
VITL icon
304
Vital Farms
VITL
$524M
$226K 0.03%
7,066
-455
-6% -$16K
ISRG icon
305
Intuitive Surgical
ISRG
$133B
$223K 0.02%
+393
New +$209K
HON icon
306
Honeywell
HON
$78.6B
$222K 0.02%
1,140
-70
-6% -$13.7K
ODFL icon
307
Old Dominion Freight Line
ODFL
$44.8B
$220K 0.02%
1,404
-992
-41% -$142K
AVY icon
308
Avery Dennison
AVY
$13.4B
$214K 0.02%
+1,178
New +$204K
FTNT icon
309
Fortinet
FTNT
$120B
$213K 0.02%
2,683
CSV icon
310
Carriage Services
CSV
$657M
$212K 0.02%
5,023
-21,909
-81% -$951K
ESI icon
311
Element Solutions
ESI
$9.34B
$212K 0.02%
8,475
VEEV icon
312
Veeva Systems
VEEV
$34.7B
$207K 0.02%
926
SNV
313
DELISTED
Synovus
SNV
$205K 0.02%
4,090
GNW icon
314
Genworth Financial
GNW
$3.71B
$202K 0.02%
22,388
-2,620
-10% -$22.8K
NTIC icon
315
Northern Technologies International Corp
NTIC
$80.5M
$196K 0.02%
25,000
BCRX icon
316
BioCryst Pharmaceuticals
BCRX
$2.31B
$171K 0.02%
21,903
-44,967
-67% -$325K
WT icon
317
WisdomTree
WT
$3.37B
$151K 0.02%
12,387
-1,438
-10% -$17.4K
NEPH icon
318
Nephros
NEPH
$38.9M
$133K 0.01%
+27,175
New +$139K
CSPI icon
319
CSP Inc
CSPI
$81.8M
$125K 0.01%
10,000
CHCI icon
320
Comstock Holding Companies
CHCI
$159M
$120K 0.01%
10,368
-17,672
-63% -$242K
CLSK icon
321
CleanSpark
CLSK
$3.46B
$102K 0.01%
+10,090
New +$151K
ACWI icon
322
iShares MSCI ACWI ETF
ACWI
$33.4B
-2,149
Closed -$297K
ADMA icon
323
ADMA Biologics
ADMA
$2.15B
-12,036
Closed -$176K
ALK icon
324
Alaska Air
ALK
$5.81B
-9,593
Closed -$478K
ANET icon
325
Arista Networks
ANET
$248B
-36,510
Closed -$5.32M

Similar funds

Navellier & Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Navellier & Associates held 390 positions worth $892M, down 9.5% from $986M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Navellier & Associates withdrew a net $101M in Q4 2025, closing 62 positions and reducing 190 holdings. Its most notable exit was Axon Enterprise, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Navellier & Associates opened a new position in Cardinal Health worth $13.1M.

  • Navellier & Associates's largest Q4 2025 buy was Cardinal Health: 63,768 shares worth $13.1M.
  • Navellier & Associates added most to Ubiquiti in Q4 2025, an estimated $6.46M increase.
  • Navellier & Associates's biggest Q4 2025 reduction was Costco, cutting an estimated $12.7M.
  • Navellier & Associates fully exited Axon Enterprise in Q4 2025, selling an estimated $10.2M.
  • Navellier & Associates's ten largest holdings make up 31% of its $892M portfolio in Q4 2025.
  • Navellier & Associates opened 36 new positions and closed 62 in Q4 2025.
  • Navellier & Associates's portfolio value fell 9.5% quarter-over-quarter to $892M.

Based on Navellier & Associates's 13F filing for Q4 2025, filed 3 Feb 2026.